Literature DB >> 8113537

Transmural heterogeneity of norepinephrine uptake in failing human hearts.

S L Beau1, J E Saffitz.   

Abstract

OBJECTIVES: The aim of this study was to determine whether regional heterogeneity in myocardial sympathetic neural function measured by the uptake of norepinephrine could account for the spatial heterogeneity of beta-adrenergic receptor down-regulation that occurs in the failing human heart.
BACKGROUND: Myocardial beta-adrenergic receptor density and function are diminished in patients with chronic heart failure. Down-regulation occurs predominantly in the subendocardium, suggesting that local rather than systemic alterations in sympathetic neural function may be responsible. Although some studies have implicated hypofunction of cardiac sympathetic nerves with defective norepinephrine uptake, others suggest increased cardiac sympathetic nerve activity with unimpaired uptake.
METHODS: We measured norepinephrine uptake by incubating transmural slices of the left ventricle from 19 patients who had chronic heart failure and three nonfailing control hearts with [3H]norepinephrine with or without desipramine, a neuronal uptake blocker. The density of uptake sites was measured in subepicardial and subendocardial myocyte regions with light microscopic autoradiography.
RESULTS: Although the amount of [3H]norepinephrine uptake varied considerably in failing ventricles, uptake was directly proportional (r = 0.46, p < 0.05) to beta 1-adrenergic receptor density measured in additional slices with radioligand binding assays. In addition, marked transmural heterogeneity in [3H] norepinephrine uptake was consistently observed in failing ventricles. Uptake in subendocardial myocyte regions was significantly less than in subepicardial regions (mean [ +/- SD] subepicardial/subendocardial uptake ratio 4.7 +/- 4.8, p < 0.01). The extent of transmural heterogeneity in norepinephrine uptake was similar in patients with idiopathic and ischemic cardiomyopathy. In contrast, nonfailing hearts exhibited more uniform transmural [3H]norepinephrine uptake (subepicardial/subendocardial uptake ratio 1.8 +/- 1.2, p = NS).
CONCLUSIONS: Specific [3H]norepinephrine accumulation is approximately fivefold lower in subendocardial regions of failing left ventricles than in subepicardial regions. These findings support the hypothesis that a subendocardial defect in norepinephrine uptake may chronically elevate local interstitial catecholamine levels and thereby down-regulate beta-adrenergic receptors in a spatially heterogeneous distribution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113537     DOI: 10.1016/0735-1097(94)90739-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.

Authors:  Erica A Wehrwein; Lindsay M Parker; Anna A Wright; John M Spitsbergen; Martin Novotny; Dagmar Babankova; Greg M Swain; Beth A Habecker; David L Kreulen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

3.  Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction.

Authors:  Marmar Vaseghi; Robert L Lux; Aman Mahajan; Kalyanam Shivkumar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-17       Impact factor: 4.733

Review 4.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

5.  Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension.

Authors:  Erica A Wehrwein; Martin Novotny; Greg M Swain; Lindsay M Parker; Mohammad Esfahanian; John M Spitsbergen; Beth A Habecker; David L Kreulen
Journal:  Auton Neurosci       Date:  2013-08-31       Impact factor: 3.145

6.  Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade.

Authors:  B Andersson; F Waagstein; K Caidahl; I Eurenius; M S Täng; R Wikh
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 7.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

8.  Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.

Authors:  E Percy; D M Kaye; G W Lambert; S Gruskin; M D Esler; X J Du
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

9.  Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts.

Authors:  Nina Kaludercic; Andrea Carpi; Takahiro Nagayama; Vidhya Sivakumaran; Guangshuo Zhu; Edwin W Lai; Djahida Bedja; Agnese De Mario; Kevin Chen; Kathleen L Gabrielson; Merry L Lindsey; Karel Pacak; Eiki Takimoto; Jean C Shih; David A Kass; Fabio Di Lisa; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2013-05-22       Impact factor: 8.401

10.  Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.

Authors:  Nina Kaludercic; Eiki Takimoto; Takahiro Nagayama; Ning Feng; Edwin W Lai; Djahida Bedja; Kevin Chen; Kathleen L Gabrielson; Randy D Blakely; Jean C Shih; Karel Pacak; David A Kass; Fabio Di Lisa; Nazareno Paolocci
Journal:  Circ Res       Date:  2009-11-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.